Charles River Laboratories International (CRL) Cost of Revenue (2016 - 2025)
Historic Cost of Revenue for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $572.6 million.
- Charles River Laboratories International's Cost of Revenue rose 69.21% to $572.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 1535.7%. This contributed to the annual value of $2.3 billion for FY2024, which is 216.89% up from last year.
- As of Q3 2025, Charles River Laboratories International's Cost of Revenue stood at $572.6 million, which was up 69.21% from $584.9 million recorded in Q2 2025.
- Charles River Laboratories International's Cost of Revenue's 5-year high stood at $664.8 million during Q3 2023, with a 5-year trough of $318.5 million in Q4 2023.
- In the last 5 years, Charles River Laboratories International's Cost of Revenue had a median value of $572.6 million in 2025 and averaged $545.1 million.
- In the last 5 years, Charles River Laboratories International's Cost of Revenue crashed by 4718.82% in 2023 and then skyrocketed by 9513.16% in 2024.
- Charles River Laboratories International's Cost of Revenue (Quarter) stood at $468.1 million in 2021, then rose by 28.85% to $603.1 million in 2022, then crashed by 47.19% to $318.5 million in 2023, then soared by 95.13% to $621.5 million in 2024, then dropped by 7.87% to $572.6 million in 2025.
- Its Cost of Revenue was $572.6 million in Q3 2025, compared to $584.9 million in Q2 2025 and $577.4 million in Q1 2025.